VentriPoint Diagnostics (TSE:VPT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ventripoint Diagnostics has secured EU CE Mark certification for its advanced AI-powered heart-scanning technology, VMS+4.0, opening new market opportunities in Europe. The VMS+4.0 offers improved user experience by automating image processing and working seamlessly with magnet-free sensors, enhancing efficiency and accuracy in cardiac measurements.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
